Response of Normal Tissues to Boron Neutron Capture Therapy (BNCT) with <sup>10</sup>B-Borocaptate Sodium (BSH) and <sup>10</sup>B-Paraboronophenylalanine (BPA)
Boron neutron capture therapy (BNCT) is a cancer-selective radiotherapy that utilizes the cancer targeting <sup>10</sup>B-compound. Cancer cells that take up the compound are substantially damaged by the high liner energy transfer (LET) particles emitted mainly from the <sup>10</sup>B(n, α<sup>7</su...
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
MDPI AG
2021-10-01
|
| Rangatū: | Cells |
| Ngā marau: | |
| Urunga tuihono: | https://www.mdpi.com/2073-4409/10/11/2883 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|